MetLife, Inc. MET NYSE

MetLife, Inc. (MET) generated $18.11B in operating cash flow for fiscal year 2025. After capital expenditures of $0.00, free cash flow was $18.11B.

Free cash flow margin was 23.5% of revenue. Cash conversion ratio was 5.36x, indicating earnings are backed by cash.

The company returned $1.51B in dividends and $3.88B in share buybacks to shareholders during the period.

Criteria supported by this page:

• HEALTH (33/100, Fail) — weak cash flow raises concerns about debt servicing
• MOAT (59/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
• INCOME (30/100) — Cash conversion ratio was 5.36x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 65/100 with 4/7 criteria passed.